In 2019, generics accounted for about 15.6 percent of the Japanese drug market, more than twice as much as in 2008, when generics held around 7.1 percent market share. That year, long-listed products made up a share of approximately 15.5 percent.
Sales share of generics in the domestic prescription drug market in Japan from 2008 to 2019
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$229 USD $199 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Major drug manufacturers Japan FY 2020, by wholesalers' sales share
- Premium Statistic Volume share of generics in prescription drug market Japan 2005-2022
- Premium Statistic Major drug manufacturers Japan 2017, by number of products
- Premium Statistic Generics drug market size Japan 2005-2020
- Premium Statistic Share of prescription drug market Japan 2010-2019 , by category
- Premium Statistic Sawai Pharmaceutical's total assets FY 2011-2020
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Basic Statistic Allocation of R&D investments in pharmaceutical industry by function 2021
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2022
- Basic Statistic Domestic purchase value of manufacture of basic pharmaceuticals in Denmark 2017-2022
About the region
10
- Premium Statistic Sawai Pharmaceutical's employee numbers 2012-2021
- Premium Statistic Astellas Pharma's net profit FY 2013-2022
- Premium Statistic Daiichi Sankyo's total assets FY 2012-2021
- Basic Statistic Sawai Pharmaceutical's sales revenue FY 2012-2021
- Premium Statistic Sawai Pharmaceutical's R&D expenditure FY 2012-201
- Premium Statistic Sawai Pharmaceutical patent numbers FY 2012-2021
- Basic Statistic Takeda Pharmaceutical's revenue FY 2012-2021
- Premium Statistic Prescription drug market sales share of LLPs Japan 2008-2019
- Premium Statistic Prescription drug market sales share of original drugs 2008-2019
- Basic Statistic Nichi-Iko's sales revenue FY 2012-2021
Selected statistics
10
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co total assets 2009-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
Other regions
10
- Premium Statistic Share of generics on public pharmaceutical expenditure in Italy 2022, by region
- Basic Statistic Sales value of generic pharmaceuticals in Sweden 2013-2022
- Basic Statistic Top drugs by sales value in Norway 2021
- Premium Statistic Total savings of top generic drugs in U.S. 2021
- Premium Statistic Share of generic drugs in the pharmaceutical market in France 2018
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Brazil: net revenue of Bayer 2013-2017
- Premium Statistic Peru's pharmaceutical and hygiene import value 2014-2018
- Premium Statistic Canadian prices for top generic molecules 2018
- Premium Statistic Main pharmacies in Mexico 2019, by size
Related statistics
10
- Premium Statistic Nichi-Iko's sales share of generics in Japan FY 2012-2021
- Premium Statistic Biosimilar market size Japan 2018-2030
- Premium Statistic Takeda Pharmaceutical's expenditure on R&D FY 2011-2020
- Premium Statistic Net sales of leading generics makers Japan 2020
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Takeda Pharmaceutical's revenue in FY 2016, by segment
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Japanese pharmaceutical companies top acquisitions as of 2014
- Basic Statistic Astellas Pharma's revenue FY 2013-2022
Further related statistics
9
- Pfizer's ad spending 2008-2022
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Expenditure worldwide on diabetes by market 2013-2018
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2008-2022
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Expenditure worldwide on diabetes by market 2013-2018
Shared Research. (June 6, 2022). Sales share of generics in the domestic prescription drug market in Japan from 2008 to 2019 [Graph]. In Statista. Retrieved October 01, 2023, from https://www.statista.com/statistics/801656/japan-drug-market-sales-share-generics/
Shared Research. "Sales share of generics in the domestic prescription drug market in Japan from 2008 to 2019." Chart. June 6, 2022. Statista. Accessed October 01, 2023. https://www.statista.com/statistics/801656/japan-drug-market-sales-share-generics/
Shared Research. (2022). Sales share of generics in the domestic prescription drug market in Japan from 2008 to 2019. Statista. Statista Inc.. Accessed: October 01, 2023. https://www.statista.com/statistics/801656/japan-drug-market-sales-share-generics/
Shared Research. "Sales Share of Generics in The Domestic Prescription Drug Market in Japan from 2008 to 2019." Statista, Statista Inc., 6 Jun 2022, https://www.statista.com/statistics/801656/japan-drug-market-sales-share-generics/
Shared Research, Sales share of generics in the domestic prescription drug market in Japan from 2008 to 2019 Statista, https://www.statista.com/statistics/801656/japan-drug-market-sales-share-generics/ (last visited October 01, 2023)
Sales share of generics in the domestic prescription drug market in Japan from 2008 to 2019 [Graph], Shared Research, June 6, 2022. [Online]. Available: https://www.statista.com/statistics/801656/japan-drug-market-sales-share-generics/